The study of the marketing strategy of the drug for hyperlipidemia to the taiwan cGMP pharmaceutical company-- The case of C pharmaceutical company

碩士 === 國立中山大學 === 企業管理學系研究所 === 96 === Abstract The rate of hyperlipidemia is increasing due to the change of people’s life style and growing aging problem in recent years. Many studies indicated that hyperlipidemia is the base of atherosclerosis which mainly causes cardiovascular diseases. Therefo...

Full description

Bibliographic Details
Main Authors: Jen-yang Yen, 顏任陽
Other Authors: Ying-Chun Li
Format: Others
Language:zh-TW
Published: 2008
Online Access:http://ndltd.ncl.edu.tw/handle/67n5cv